P08.60 RAMBO (rapid anti angiogenesis mediated by oncolytic virus) decreased bevacizumab-induced glioma cell invasion

INTRODUCTION: Anti-VEGF therapies such as bevacizumab have been shown to attenuate VEGF-mediated angiogenesis, to decrease vascular permeability, and to inhibit tumor growth in malignant glioma. Conversely, bevacizumab has also been reported to induce invasive proliferation. Oncolytic viral therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Tomita, Y., Kurozumi, K., Shimizu, T., Oka, T., Otani, Y., Ishida, J., Fujii, K., Kaur, B., Tomotsugu, I., Date, I.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
POSTER PRESENTATIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464039/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.249
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados